This prescription is used to improve glycemic control and help in weight loss
Originally developed for managing Type 2 diabetes, it has also been shown to aid in weight loss by helping individuals feel fuller for longer and reducing cravings
The phase 2 trials clearly demonstrated a dose-dependent response, with higher doses leading to greater weight loss
Its unique ability to cross the blood-brain barrier allows it to positively influence neurotransmitter activity, supporting memory, learning, and overall mental clarity
Semaglutide use is particularly relevant when evaluating abdominal pain (pancreatitis risk), severe nausea or vomiting (common adverse effects), or hypoglycemia
The increase in eumelanin provides enhanced photoprotection against ultraviolet (UV) radiation